{"id":"NCT05274269","sponsor":"Vertex Pharmaceuticals Incorporated","briefTitle":"Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation","officialTitle":"A Phase 3 Double-blind, Randomized, Placebo-controlled Study Evaluating the Efficacy and Safety of ELX/TEZ/IVA in Cystic Fibrosis Subjects 6 Years of Age and Older With a Non-F508del ELX/TEZ/IVA-responsive CFTR Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-05-09","primaryCompletion":"2023-07-05","completion":"2023-07-05","firstPosted":"2022-03-10","resultsPosted":"2024-08-01","lastUpdate":"2024-08-01"},"enrollment":307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cystic Fibrosis"],"interventions":[{"type":"DRUG","name":"ELX/TEZ/IVA","otherNames":["VX-445/VX-661/VX-770","elexacaftor/tezacaftor/ivacaftor"]},{"type":"DRUG","name":"IVA","otherNames":["VX-770","ivacaftor"]},{"type":"OTHER","name":"Placebo (matched to ELX/TEZ/IVA)","otherNames":[]},{"type":"OTHER","name":"Placebo (matched to IVA)","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"ELX/TEZ/IVA","type":"EXPERIMENTAL"}],"summary":"This study evaluated the efficacy, pharmacodynamics (PD) and safety of ELX/TEZ/IVA in participants 6 years of age and older with a non-F508del ELX/TEZ/IVA-responsive cystic fibrosis transmembrane conductance regulator gene (CFTR) mutation.","primaryOutcome":{"measure":"Absolute Change in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1)","timeFrame":"From Baseline Through Week 24","effectByArm":[{"arm":"Placebo","deltaMin":-0.4,"sd":null},{"arm":"ELX/TEZ/IVA","deltaMin":8.9,"sd":null}],"pValues":[{"comp":"OG000","p":"< 0.0001"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":90,"countries":["Austria","Belgium","Canada","Czechia","France","Germany","Hungary","Italy","Netherlands","Norway","Poland","Portugal","Spain","Sweden","Switzerland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":102},"commonTop":["Infective pulmonary exacerbation of cystic fibrosis","Nasopharyngitis","Cough","Headache","Rash"]}}